Dale Barwick
Adult Health · Summerton, SCNPI 1114052255
Payments from drug & device makers
Across 194 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$713
- AstraZeneca$374
- Novo Nordisk$336
- Johnson & Johnson$238
- Bayer$150
- Amgen$143
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $713 |
| AstraZeneca | 18 | $374 |
| Novo Nordisk | 24 | $336 |
| Johnson & Johnson | 16 | $238 |
| Bayer | 11 | $150 |
| Amgen | 5 | $143 |
| Novartis | 8 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $122 |
| Amarin Pharma, Inc. | 7 | $120 |
| Abbott | 7 | $113 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $62 |
| Exact Sciences | 3 | $62 |
| Pfizer | 4 | $61 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| Biohaven Pharmaceuticals, Inc. | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Adlon Therapeutics L.p. | 2 | $38 |
| Optinose US, Inc. | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| GSK | 2 | $25 |
| Stryker | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Lilly USA, LLC | 2 | $24 |
| Shield Therapeutics Inc | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $7 |
How this compares
$3,196 in reported general payments places this provider in the 75th percentile of 292 adult health providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 106 | $115,890 |
| JardianceEmpagliflozin | 90 | $85,838 |
| RybelsusSemaglutide | 34 | $67,638 |
| MounjaroTirzepatide | 50 | $66,604 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $52,646 |
| FarxigaDapagliflozin Propanediol | 54 | $52,322 |
| TrulicityDulaglutide | 29 | $41,745 |
| EliquisApixaban | 53 | $36,037 |
| CreonLipase/Protease/Amylase | 13 | $16,669 |
| EntrestoSacubitril/Valsartan | 18 | $16,035 |
| TradjentaLinagliptin | 18 | $9,339 |
| Repatha SureclickEvolocumab | 12 | $8,749 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $7,496 |
| LinzessLinaclotide | 11 | $5,223 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $4,021 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $336 | $183,528140 claims |
| Lilly USA, LLCMounjaro, Trulicity | $24 | $108,34979 claims |
| Boehringer IngelheimJardiance, Tradjenta | $16 | $95,178108 claims |
| GSKTrelegy Ellipta | $25 | $52,64657 claims |
| AstraZenecaFarxiga | $374 | $52,32254 claims |
| PfizerEliquis | $61 | $36,03753 claims |
| AbbVieCreon, Linzess | $713 | $21,89224 claims |
| NovartisEntresto | $131 | $16,03518 claims |
| MerckJanumet | $13 | $7,49613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 292 adult health providers in South Carolina.
Other adult health in Summerton
- Karen RobertsonGreenville$69K
- Christine FranzeseTega Cay$30K
- Jessica RiceGreenville$15K
- Michelle PriceCharleston$13K
- Melissa McCarterSpartanburg$12K
- Andrea OlsonWest Columbia$12K
- Jennifer BrittIrmo$11K
- Nichole SnowSpartanburg$10K
- Christi WigginsWest Columbia$10K
- Mary BairdSumter$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.